Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD

Recruiting

Phase 2

SildenafilOral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD

Sponsor:

University of Alberta

Code:

NCT05061368

Conditions

Chronic Obstructive Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Accepted

Interventions

Sildenafil Citrate

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-25. This information was provided to ClinicalTrials.gov by University of Alberta on 2025-11-18.